ReviewMolecules (Basel, Switzerland)2025
Recent Advances in Bioactive Compounds, Health Functions, and Utilization of Rose (
Review in Molecules (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Pharmacological insights into the antidiabetic potential ofToxicology reports · 2026Article
- Physicochemical and Functional Properties of Polyphenolic Core Gel Microcapsules from Rose Petals (Foods (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Our review systematically outlines the bioactivity and industrial applications of key functional compounds in roses, with a particular focus on their potential in food and pharmaceutical industries from technical, economic, and commercialization perspectives. We summarize the evidence supporting the efficacy of rose-derived polyphenols, flavonoids, and essential oils in areas including antioxidant, anti-inflammatory, antibacterial, and neuroprotective effects, which provide a scientific basis for their use in functional foods and preventive medicines. We further evaluated the commercial viability of processing rose by-products. Additionally, we analyze current and potential applications of rose bioactive compounds in natural food preservatives, functional dietary supplements, herbal medicines, and cosmetic products. Finally, we discuss the remaining challenges and future directions for the industrial utilization of roses, including standardization, efficacy validation in humans, and scalable economic models, to facilitate the transition from experimental research to commercially sustainable applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.